SELECTIVE CORTICAL DECREASE OF HIGH-AFFINITY CHOLINE UPTAKE CARRIER IN ALZHEIMERS-DISEASE - AN AUTORADIOGRAPHIC STUDY USING H-3 HEMICHOLINIUM-3

被引:27
|
作者
RODRIGUEZPUERTAS, R
PAZOS, A
ZARRANZ, JJ
PASCUAL, J
机构
[1] UNIV CANTABRIA,UNIV HOSP MARQUES VALDECILLA,DEPT MED,SERV NEUROL,E-39008 SANTANDER,SPAIN
[2] UNIV CANTABRIA,UNIV HOSP MARQUES VALDECILLA,DEPT PHYSIOL & PHARMACOL,PHARMACOL UNIT,E-39008 SANTANDER,SPAIN
[3] UNIV BASQUE COUNTRY,DEPT NEUROSCI,LEIOA,SPAIN
关键词
ALZHEIMERS DISEASE; H-3; HEMICHOLINIUM-3; HIGH-AFFINITY CHOLINE UPTAKE;
D O I
10.1007/BF02260937
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
H-3-hemicholinium-3 (H-3-HC-3) binding, a marker of the presynaptic high-affinity choline uptake carrier (HACU), was measured by autoradiography in several brain regions of 17 Alzheimer's disease (AD) patients and of 11 matched controls. A significant decrease in the density of H-3-HC-3 binding sites was found in entorhinal cortex, hippocampus and layers I-III of the frontal cortex. By contrast, in the caudate-putamen the number of H-3-HC-3 binding sites in AD cases was comparable to that of control striata. These data concur with previous results using classical presynaptic markers and reflect the loss in the activity of HACU, and, hence, in the synthesis of acetylcholine, that selectively occurs in cortical areas of AD brains due to the degeneration of presynaptic cholinergic terminals arising from the basal forebrain. However, the relatively low mean reduction in HACU in cortical areas (-40%), together with the apparent indemnity of this marker in certain severely demented AD cases, suggest that AD dementia cannot be explained simply by the loss of presynaptic terminals originating in the basal forebrain. These data seem to be a good explanation for the poor response to cholinergic replacement in AD.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 50 条